[HTML][HTML] Mechanisms of thrombosis in ANCA-associated vasculitis
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
[PDF][PDF] Mechanisms of thrombosis in ANCA‑associated vasculitis
DP Misra, KN Thomas, AY Gasparyan, O Zimba - 2021 - researchgate.net
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
Mechanisms of thrombosis in ANCA-associated vasculitis.
DP Misra, KN Thomas, AY Gasparyan… - Clinical …, 2021 - europepmc.org
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
[HTML][HTML] Mechanisms of thrombosis in ANCA-associated vasculitis
DP Misra, KN Thomas, AY Gasparyan… - Clinical …, 2021 - ncbi.nlm.nih.gov
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
Mechanisms of thrombosis in ANCA-associated vasculitis.
DP Misra, KN Thomas, AY Gasparyan… - Clinical …, 2021 - search.ebscohost.com
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
Mechanisms of thrombosis in ANCA-associated vasculitis
DP Misra, KN Thomas, AY Gasparyan… - Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
Mechanisms of thrombosis in ANCA-associated vasculitis
DP Misra, TK Nithin, AY Gasparyan… - Clinical …, 2021 - search.proquest.com
Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …
[引用][C] Mechanisms of thrombosis in ANCA-associated vasculitis
DP Misra, KN Thomas, AY Gasparyan, O Zimba - Clinical Rheumatology, 2021 - elibrary.ru
[引用][C] Mechanisms of thrombosis in ANCA-associated vasculitis
DP Misra, KN Thomas, AY Gasparyan, O Zimba - Clinical Rheumatology, 2021 - cir.nii.ac.jp
Mechanisms of thrombosis in ANCA-associated vasculitis | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …